Prostaglandin E2 Signaling: Alternative Target for Glioblastoma?

被引：62
|
作者：
Jiang, Jianxiong [1 ]
Qiu, Jiange [1 ,2 ,3 ]
Li, Qianqian [1 ]
Shi, Zhi [2 ,3 ]
机构：
[1] Univ Cincinnati, Acad Hlth Ctr, James L Winkle Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
[2] Jinan Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med,Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China
[3] Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China
来源：
TRENDS IN CANCER | 2017年 / 3卷 / 02期
基金：
美国国家卫生研究院; 中国国家自然科学基金;
关键词：
GLIOMA-CELL GROWTH; RECEPTOR EP2; E SYNTHASE-1; INFLAMMATION; MICROGLIA; SURVIVAL; CANCER;
D O I：
10.1016/j.trecan.2016.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Elevated cyclooxygenase-2 (COX-2) and the associated inflammation within the brain contribute to glioblastoma development. However, medical use of COX inhibitors in glioblastoma treatment has been limited due to their well-documented vascular toxicity and inconsistent outcomes from recent human studies. Prostaglandin E2 (PGE2) has emerged as a principal mediator for COX-2 cascade-driven gliomagenesis. Are PGE(2) terminal synthases and receptors feasible therapeutic targets for glioblastoma?
引用
收藏
页码：75 / 78
页数：4
相关论文
共 50 条
  • [21] Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease
    Shi, Ju
    Wang, Qian
    Johansson, Jenny U.
    Liang, Xibin
    Woodling, Nathaniel S.
    Priyam, Prachi
    Loui, Taylor M.
    Merchant, Milton
    Breyer, Richard M.
    Montine, Thomas J.
    Andreasson, Katrin
    ANNALS OF NEUROLOGY, 2012, 72 (05) : 788 - 798
  • [22] Polymorphisms predicted to alter function in Prostaglandin E2 synthase and Prostaglandin E2 receptors
    Bigler, Jeannette
    Sibert, Justin G.
    Poole, Elizabeth M.
    Carlson, Christopher S.
    Potter, John D.
    Ulrich, Cornelia M.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (03): : 221 - 227
  • [23] Genetic Variation in Prostaglandin E2 Synthesis and Signaling, Prostaglandin Dehydrogenase, and the Risk of Colorectal Adenoma
    Poole, Elizabeth M.
    Hsu, Li
    Xiao, Liren
    Kulmacz, Richard J.
    Carlson, Christopher S.
    Rabinovitch, Peter S.
    Makar, Karen W.
    Potter, John D.
    Ulrich, Cornelia M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (02) : 547 - 557
  • [24] Regulation of Prostaglandin E2 signaling by cysteinyl leukotrienes in human mast cells
    Kondeti, Vinay
    Duah, Ernest
    Emory, Ashley
    Thodeti, Charles K.
    Paruchuri, Sailaja
    FASEB JOURNAL, 2013, 27
  • [25] Prostaglandin E2 Suppression Of Myofibroblast Differentiation Is Mediated By The PKA Signaling Pathway
    Garrison, G.
    Huang, S. K.
    Wettlaufer, S. H.
    Okunishi, K.
    Peters-Golden, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [26] The role of prostaglandin E2 receptor signaling of dendritic cells in rheumatoid arthritis
    Jia, Xiao-Yi
    Chang, Yan
    Sun, Xiao-Jing
    Dai, Xing
    Wei, Wei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 23 (01) : 163 - 169
  • [27] Phosphoproteomics-Based Characterization of Prostaglandin E2 Signaling in T Cells
    Lone, Anna Mari
    Tasken, Kjetil
    MOLECULAR PHARMACOLOGY, 2021, 99 (05) : 370 - 382
  • [28] Prostaglandin E2 Inhibits Calcium Signaling In Normal And Ipf Pulmonary Fibroblasts
    Mukherjee, S.
    Kolb, M. R. J.
    Janssen, L. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] Prevotella intermedia Induces Prostaglandin E2 via Multiple Signaling Pathways
    Guan, S. -M.
    Fu, S. -M.
    He, J. -J.
    Zhang, M.
    JOURNAL OF DENTAL RESEARCH, 2011, 90 (01) : 121 - 127
  • [30] Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy
    Taniguchi, Hidetoshi
    Anacker, Christoph
    Wang, Qian
    Andreasson, Katrin
    EXPERIMENTAL NEUROLOGY, 2014, 255 : 30 - 37
12345